№ |
НАЗВА |
Print-ISSN
|
Active or Inactive
|
Article language in source(three-letter ISO language codes)
|
Publisher's Name
|
Publisher imprints grouped to main Publisher
|
Publisher's Country
|
All Science Classification Codes (ASJC)
|
2016 CiteScore
|
2016
SJR
|
2016
SNIP
|
Related title to title history indication
|
E-ISSN
|
5851 () |
Cancer Biology and Medicine
|
20953941
|
Active
|
ENG
|
Chinese Anticancer Association
|
Chinese Anticancer Association
|
China
|
Cancer Research Oncology
|
4.11
|
1.401
|
1.152
|
|
|
5852 () |
Cancer Biology and Therapy
|
15384047
|
Active
|
ENG
|
Landes Bioscience
|
Taylor & Francis
|
United States
|
Cancer Research Pharmacology Oncology Molecular Medicine
|
2.96
|
1.131
|
0.743
|
|
|
5853 () |
Cancer Biomarkers
|
15740153
|
Active
|
ENG
|
IOS Press
|
IOS Press
|
Netherlands
|
Cancer Research Genetics Oncology General Medicine
|
1.94
|
0.662
|
0.530
|
|
|
5854 () |
Cancer Biotherapy
|
10628401
|
Inactive
|
|
Mary Ann Liebert Inc.
|
Mary Ann Liebert
|
United States
|
Cancer Research Pharmacology
|
|
|
|
Selective Cancer Therapeutics
|
|
5855 () |
Cancer Biotherapy and Radiopharmaceuticals
|
10849785
|
Active
|
ENG
|
Mary Ann Liebert Inc.
|
Mary Ann Liebert
|
United States
|
Cancer Research Pharmacology Radiology Nuclear Medicine and imaging Oncology General Medicine
|
1.92
|
0.661
|
0.659
|
Antibody, Immunoconjugates, and Radiopharmaceuticals
|
|
5856 () |
Cancer Bulletin
|
0740820X
|
Inactive
|
|
Medical Arts Publishing
|
Medical Arts Publishing
|
United States
|
Cancer Research
|
|
|
|
Texas cancer bulletin
|
|
5857 () |
Cancer Case Presentations: The Tumor Board
|
10907491
|
Inactive
|
|
Lippincott Williams & Wilkins Ltd.
|
Wolters Kluwer Health
|
United States
|
Oncology Surgery
|
|
|
|
|
|
5858 () |
Cancer Causes and Control
|
9575243
|
Active
|
ENG
|
Kluwer Academic Publishers
|
Springer Nature
|
Netherlands
|
Cancer Research Oncology
|
2.70
|
1.421
|
0.896
|
|
15737225
|
5859 () |
Cancer Cell
|
15356108
|
Active
|
ENG
|
Cell Press
|
Elsevier
|
United States
|
Cancer Research Cell Biology Oncology
|
16.19
|
13.169
|
4.944
|
|
|
5860 () |
Cancer Cell International
|
14752867
|
Active
|
ENG
|
BioMed Central
|
Springer Nature
|
United Kingdom
|
Cancer Research Genetics Oncology
|
3.14
|
1.006
|
0.897
|
|
|
5861 () |
Cancer chemotherapy and biological response modifiers
|
9214410
|
Inactive
|
|
Elsevier BV
|
Elsevier
|
Netherlands
|
General Medicine
|
|
|
|
|
|
5862 () |
Cancer Chemotherapy and Pharmacology
|
3445704
|
Active
|
ENG
|
Springer Verlag
|
Springer Nature
|
Germany
|
Pharmacology (medical) Cancer Research Pharmacology Toxicology Oncology
|
2.96
|
1.186
|
0.919
|
|
|
5863 () |
Cancer Chemotherapy and Pharmacology, Supplement
|
9439404
|
Inactive
|
|
Springer Verlag
|
Springer Nature
|
Germany
|
Cancer Research Pharmacology Oncology
|
|
|
|
|
|
5864 () |
Cancer chemotherapy reports. Part 1
|
690112
|
Inactive
|
|
National Cancer Institute
|
National Cancer Institute
|
United States
|
General Medicine
|
|
|
|
Cancer Treatment Reports
|
|
5865 () |
Cancer chemotherapy reports. Part 2
|
690120
|
Inactive
|
|
U.S. National Cancer Institute
|
U.S. National Cancer Institute
|
United States
|
General Medicine
|
|
|
|
Cancer Treatment Reports
|
|
5866 () |
Cancer chemotherapy reports. Part 3
|
690139
|
Inactive
|
|
Cancer Chemotherapy National Service Center
|
Cancer Chemotherapy National Service Center
|
United States
|
General Medicine
|
|
|
|
Cancer Treatment Reports
|
|
5867 () |
Cancer Clinical Trials
|
0190Conservation
|
Inactive
|
|
Masson Publishing
|
Elsevier
|
France
|
General Medicine
|
|
|
|
American journal of clinical oncology : the official publication of the American Radium Society
|
|
5868 () |
Cancer Communications
|
9553541
|
Inactive
|
|
Pergamon Press Ltd.
|
Elsevier
|
United Kingdom
|
Cancer Research
|
|
|
|
Oncology Research
|
|
5869 () |
Cancer Control
|
10732748
|
Active
|
ENG
|
Moffitt Cancer Center
|
Moffitt Cancer Center
|
United States
|
Oncology Hematology General Medicine
|
2.38
|
0.992
|
1.320
|
|
15262359
|
5870 () |
Cancer Cytopathology
|
1934662X
|
Active
|
ENG
|
Wiley-Blackwell
|
Wiley-Blackwell
|
United States
|
Cancer Research Oncology
|
2.76
|
1.228
|
1.131
|
|
19346638
|
5871 () |
Cancer Detection and Prevention
|
0361090X
|
Inactive
|
|
Elsevier BV
|
Elsevier
|
Netherlands
|
Cancer Research Oncology
|
|
|
|
Cancer Epidemiology
|
15251500
|
5872 () |
Cancer Discovery
|
21598274
|
Active
|
ENG
|
American Association for Cancer Research Inc.
|
American Association for Cancer Research Inc.
|
United States
|
Oncology
|
3.46
|
4.455
|
2.082
|
|
21598290
|
5873 () |
Cancer Drug Delivery
|
7329482
|
Inactive
|
|
Mary Ann Liebert Inc.
|
Mary Ann Liebert
|
United States
|
Cancer Research Pharmacology
|
|
|
|
Selective Cancer Therapeutics
|
|
5874 () |
Cancer Drug Discovery and Development
|
21969914
|
Active
|
ENG
|
Humana Press Inc.
|
Springer Nature
|
United States
|
Cancer Research Drug Discovery Oncology
|
0.00
|
0.102
|
0.000
|
|
|
5875 () |
Cancer Epidemiology
|
18777821
|
Active
|
ENG
|
Elsevier BV
|
Elsevier
|
Netherlands
|
Cancer Research Oncology Epidemiology
|
2.59
|
1.190
|
1.050
|
Cancer Detection and Prevention
|
|
5876 () |
Cancer Epidemiology Biomarkers and Prevention
|
10559965
|
Active
|
ENG
|
American Association for Cancer Research
|
American Association for Cancer Research
|
United States
|
Oncology Epidemiology
|
3.95
|
2.527
|
1.326
|
|
|
5877 () |
Cancer Forum
|
0311306X
|
Active
|
ENG
|
Cancer Council Australia
|
Cancer Council Australia
|
Australia
|
Cancer Research Oncology
|
0.17
|
0.146
|
0.091
|
|
|
5878 () |
Cancer Gene Therapy
|
9291903
|
Active
|
ENG
|
Nature Publishing Group
|
Springer Nature
|
United Kingdom
|
Cancer Research Molecular Biology Molecular Medicine
|
3.11
|
1.080
|
0.758
|
|
|
5879 () |
Cancer genetics
|
22107762
|
Active
|
ENG
|
Elsevier BV
|
Elsevier
|
Netherlands
|
Cancer Research Genetics Molecular Biology
|
2.18
|
1.175
|
0.656
|
|
|
5880 () |
Cancer Genetics and Cytogenetics
|
1654608
|
Inactive
|
|
Elsevier BV
|
Elsevier
|
Netherlands
|
Cancer Research Genetics Molecular Biology
|
|
|
|
|
|